Guiping Ren

Prof. Guiping Ren


Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2015 in Pharmacology Biochemistry and Behavior
Verified
Journal Article
Closed access
YYYinhang Yu
Yinhang Yu
FBFuliang Bai
Fuliang Bai
WWWenfei Wang
Wenfei Wang
YLYaonan Liu
Yaonan Liu
QYQingyan Yuan
Qingyan Yuan
GRGuiping Ren
Guiping Ren

21 February 2015 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
YYYinhang Yu
Yinhang Yu
FBFuliang Bai
Fuliang Bai
YLYaonan Liu
Yaonan Liu
YYYongbi Yang
Yongbi Yang
QYQingyan Yuan
Qingyan Yuan
DLDeshan Li
Deshan Li

1 January 2016 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
PXPengfei Xu
Pengfei Xu
YZYingjie Zhang
Yingjie Zhang
YLYunye Liu
Yunye Liu
QYQingyan Yuan
Qingyan Yuan
LSLiying Song
Liying Song
GRGuiping Ren
Guiping Ren

29 October 2014 in Acta Biochimica et Biophysica Sinica
Verified
Journal Article
Open access
PDF file
SZShenglong Zhu
Shenglong Zhu
LMLei Ma
Lei Ma
YWYunzhou Wu
Yunzhou Wu
XYXianlong Ye
Xianlong Ye
TZTianyuan Zhang
Tianyuan Zhang
DLDeshan Li
Deshan Li
Fibroblast growth factor 21 (FGF21), a recently identified member of the FGF superfamily, is mainly secreted from the liver and adipose tissues and plays an important role in improving metabolic syndrome and homeostasis. The aim of this study is to evaluate the role of FGF21 in alcoholic fatty liver disease (AFLD) and to determine if it has a therapeutic effect on AFLD. In this paper, we tested the effect of FGF21 on alcohol-induced liver injury in a murine model of chronic ethanol gavage and alcohol-treated HepG2 cells. Male KM mice received single dose of 5 g/kg ethanol gavage every day for 6 weeks, which induced significant fatty liver and liver injury. The alcohol-induced fatty liver cell model was achieved by adding ethanol into the medium of HepG2 cell cultures at a final concentration of 75 mM for 9 days. Results showed that treatment with recombinant FGF21 ameliorated alcoholic fatty liver and liver injury both in a murine model of chronic ethanol gavage and alcohol-treated HepG2 cells. In addition, FGF21 treatment down-regulated the hepatic expression of fatty acid synthetic key enzyme, activated hepatic AMPK-SIRT1 pathway and significantly down-regulated hepatic oxidative stress protein. Taken together, FGF21 corrects multiple metabolic parameters of AFLD in vitro and in vivo by activation of the AMPK-SIRT1 pathway.

1 March 2015 in International Immunopharmacology
Verified
Journal Article
Closed access
YYYinhang Yu
Yinhang Yu
SLSiming Li
Siming Li
YLYaonan Liu
Yaonan Liu
GTGuiyou Tian
Guiyou Tian
QYQingyan Yuan
Qingyan Yuan
DLDeshan Li
Deshan Li

19 July 2016 in Molecular and Cellular Biochemistry
Verified
Journal Article
Closed access
PDF file
SZShenglong Zhu
Shenglong Zhu
YWYunzhou Wu
Yunzhou Wu
XYXianlong Ye
Xianlong Ye
YCYongQ Chen
YongQ Chen
JQJianying Qi
Jianying Qi
DLDeshan Li
Deshan Li